HI
GOSS icon

Harbour Investments’s Gossamer Bio GOSS Stock Holding History

Harbour Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-105
Closed -$1K – 3059
2021
Q3 		$1K Hold
105
– – ﹤0.01% 3510
2021
Q2 		$1K Hold
105
– – ﹤0.01% 3562
2021
Q1 		$1K Buy
+105
New +$1.06K ﹤0.01% 3390

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Harbour Investments's GOSS Position: Q4 2021 in Review

Harbour Investments sold out of Gossamer Bio (GOSS) in Q4 2021, closing a stake of 105 shares — an estimated $1K sold.

Harbour Investments first reported a position in GOSS in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 133 funds tracked by Wall St. Rank hold GOSS as of Q4 2021.

  • Harbour Investments reported no remaining Gossamer Bio position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 105 Gossamer Bio shares in Q4 2021, an estimated $1K.
  • Harbour Investments first reported a position in Gossamer Bio in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Gossamer Bio position peaked at $1K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.